Aldosterone activates the oncogenic signals ERK1/2 and STAT3 via redox-regulated mechanisms

Nina Queisser, Nicole Schupp, Eva Schwarz, Christina Hartmann, Gerardo Mackenzie, Patricia I. Oteiza

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Epidemiological studies found an increased risk for kidney cancer in hypertensive patients, of which a subgroup has high aldosterone (Ald) levels. We recently showed that Ald is genotoxic both in kidney tubular cells and in rats with mineralocorticoid-mediated hypertension. The present work investigated in vitro and in vivo, if the oxidative stress-mediated activation of the ERK1/2 pathway, and its downstream target STAT3, could be one mechanism involved in the potential oncogenic capability of excess Ald exposure. The effects of excess Ald were investigated in LLC-PK1 cells and in Ald-induced hypertensive rats. Ald caused cRaf, MEK1/2, and ERK1/2 phosphorylation both in LLC-PK1 cells and in rat kidneys. ERK1/2 activation led to an increased phosphorylation of MSK1, p90RSK, and STAT3. The involvement of ERK1/2 in the activation of STAT3 was evidenced by the capacity of the MEK inhibitor U0126 to prevent Ald-mediated ERK1/2 and STAT3 phosphorylation. Both in vitro and in vivo, the activation of ERK1/2 and STAT3 by Ald was dependent on the mineralocorticoid receptor and was triggered by an increase in cellular oxidants. Ald-mediated oxidant increase was in part due to the activation of the enzymes NADPH oxidase and NO synthase. Proliferation was significantly enhanced and apoptosis decreased in Ald-treated rat kidneys and/or LLC-PK1 cells. Results support the concept that the oxidant-mediated long-term activation of ERK1/2/STAT3 by persistently high Ald levels could trigger proliferative and prosurvival events. Ald-mediated promotion of cell survival and DNA damage could result in kidney cell transformation and initiation of cancer in hypertensive patients with hyperaldosteronism.

Original languageEnglish (US)
Pages (from-to)1868-1883
Number of pages16
JournalMolecular Carcinogenesis
Volume56
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Aldosterone
Oxidation-Reduction
LLC-PK1 Cells
Oxidants
Kidney
Phosphorylation
Mineralocorticoid Receptors
Mineralocorticoids
Hyperaldosteronism
Enzyme Activation
MAP Kinase Signaling System
Kidney Neoplasms
NADPH Oxidase
Mitogen-Activated Protein Kinase Kinases
Nitric Oxide Synthase
DNA Damage
Epidemiologic Studies
Cell Survival
Oxidative Stress
Apoptosis

Keywords

  • aldosterone
  • ERK1/2
  • kidney cancer
  • oxidative stress
  • STAT3

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Aldosterone activates the oncogenic signals ERK1/2 and STAT3 via redox-regulated mechanisms. / Queisser, Nina; Schupp, Nicole; Schwarz, Eva; Hartmann, Christina; Mackenzie, Gerardo; Oteiza, Patricia I.

In: Molecular Carcinogenesis, Vol. 56, No. 8, 01.08.2017, p. 1868-1883.

Research output: Contribution to journalArticle

Queisser, Nina ; Schupp, Nicole ; Schwarz, Eva ; Hartmann, Christina ; Mackenzie, Gerardo ; Oteiza, Patricia I. / Aldosterone activates the oncogenic signals ERK1/2 and STAT3 via redox-regulated mechanisms. In: Molecular Carcinogenesis. 2017 ; Vol. 56, No. 8. pp. 1868-1883.
@article{904a7b65ba6947db9a10ded8c9dd4699,
title = "Aldosterone activates the oncogenic signals ERK1/2 and STAT3 via redox-regulated mechanisms",
abstract = "Epidemiological studies found an increased risk for kidney cancer in hypertensive patients, of which a subgroup has high aldosterone (Ald) levels. We recently showed that Ald is genotoxic both in kidney tubular cells and in rats with mineralocorticoid-mediated hypertension. The present work investigated in vitro and in vivo, if the oxidative stress-mediated activation of the ERK1/2 pathway, and its downstream target STAT3, could be one mechanism involved in the potential oncogenic capability of excess Ald exposure. The effects of excess Ald were investigated in LLC-PK1 cells and in Ald-induced hypertensive rats. Ald caused cRaf, MEK1/2, and ERK1/2 phosphorylation both in LLC-PK1 cells and in rat kidneys. ERK1/2 activation led to an increased phosphorylation of MSK1, p90RSK, and STAT3. The involvement of ERK1/2 in the activation of STAT3 was evidenced by the capacity of the MEK inhibitor U0126 to prevent Ald-mediated ERK1/2 and STAT3 phosphorylation. Both in vitro and in vivo, the activation of ERK1/2 and STAT3 by Ald was dependent on the mineralocorticoid receptor and was triggered by an increase in cellular oxidants. Ald-mediated oxidant increase was in part due to the activation of the enzymes NADPH oxidase and NO synthase. Proliferation was significantly enhanced and apoptosis decreased in Ald-treated rat kidneys and/or LLC-PK1 cells. Results support the concept that the oxidant-mediated long-term activation of ERK1/2/STAT3 by persistently high Ald levels could trigger proliferative and prosurvival events. Ald-mediated promotion of cell survival and DNA damage could result in kidney cell transformation and initiation of cancer in hypertensive patients with hyperaldosteronism.",
keywords = "aldosterone, ERK1/2, kidney cancer, oxidative stress, STAT3",
author = "Nina Queisser and Nicole Schupp and Eva Schwarz and Christina Hartmann and Gerardo Mackenzie and Oteiza, {Patricia I.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1002/mc.22643",
language = "English (US)",
volume = "56",
pages = "1868--1883",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Aldosterone activates the oncogenic signals ERK1/2 and STAT3 via redox-regulated mechanisms

AU - Queisser, Nina

AU - Schupp, Nicole

AU - Schwarz, Eva

AU - Hartmann, Christina

AU - Mackenzie, Gerardo

AU - Oteiza, Patricia I.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Epidemiological studies found an increased risk for kidney cancer in hypertensive patients, of which a subgroup has high aldosterone (Ald) levels. We recently showed that Ald is genotoxic both in kidney tubular cells and in rats with mineralocorticoid-mediated hypertension. The present work investigated in vitro and in vivo, if the oxidative stress-mediated activation of the ERK1/2 pathway, and its downstream target STAT3, could be one mechanism involved in the potential oncogenic capability of excess Ald exposure. The effects of excess Ald were investigated in LLC-PK1 cells and in Ald-induced hypertensive rats. Ald caused cRaf, MEK1/2, and ERK1/2 phosphorylation both in LLC-PK1 cells and in rat kidneys. ERK1/2 activation led to an increased phosphorylation of MSK1, p90RSK, and STAT3. The involvement of ERK1/2 in the activation of STAT3 was evidenced by the capacity of the MEK inhibitor U0126 to prevent Ald-mediated ERK1/2 and STAT3 phosphorylation. Both in vitro and in vivo, the activation of ERK1/2 and STAT3 by Ald was dependent on the mineralocorticoid receptor and was triggered by an increase in cellular oxidants. Ald-mediated oxidant increase was in part due to the activation of the enzymes NADPH oxidase and NO synthase. Proliferation was significantly enhanced and apoptosis decreased in Ald-treated rat kidneys and/or LLC-PK1 cells. Results support the concept that the oxidant-mediated long-term activation of ERK1/2/STAT3 by persistently high Ald levels could trigger proliferative and prosurvival events. Ald-mediated promotion of cell survival and DNA damage could result in kidney cell transformation and initiation of cancer in hypertensive patients with hyperaldosteronism.

AB - Epidemiological studies found an increased risk for kidney cancer in hypertensive patients, of which a subgroup has high aldosterone (Ald) levels. We recently showed that Ald is genotoxic both in kidney tubular cells and in rats with mineralocorticoid-mediated hypertension. The present work investigated in vitro and in vivo, if the oxidative stress-mediated activation of the ERK1/2 pathway, and its downstream target STAT3, could be one mechanism involved in the potential oncogenic capability of excess Ald exposure. The effects of excess Ald were investigated in LLC-PK1 cells and in Ald-induced hypertensive rats. Ald caused cRaf, MEK1/2, and ERK1/2 phosphorylation both in LLC-PK1 cells and in rat kidneys. ERK1/2 activation led to an increased phosphorylation of MSK1, p90RSK, and STAT3. The involvement of ERK1/2 in the activation of STAT3 was evidenced by the capacity of the MEK inhibitor U0126 to prevent Ald-mediated ERK1/2 and STAT3 phosphorylation. Both in vitro and in vivo, the activation of ERK1/2 and STAT3 by Ald was dependent on the mineralocorticoid receptor and was triggered by an increase in cellular oxidants. Ald-mediated oxidant increase was in part due to the activation of the enzymes NADPH oxidase and NO synthase. Proliferation was significantly enhanced and apoptosis decreased in Ald-treated rat kidneys and/or LLC-PK1 cells. Results support the concept that the oxidant-mediated long-term activation of ERK1/2/STAT3 by persistently high Ald levels could trigger proliferative and prosurvival events. Ald-mediated promotion of cell survival and DNA damage could result in kidney cell transformation and initiation of cancer in hypertensive patients with hyperaldosteronism.

KW - aldosterone

KW - ERK1/2

KW - kidney cancer

KW - oxidative stress

KW - STAT3

UR - http://www.scopus.com/inward/record.url?scp=85017395757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017395757&partnerID=8YFLogxK

U2 - 10.1002/mc.22643

DO - 10.1002/mc.22643

M3 - Article

VL - 56

SP - 1868

EP - 1883

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 8

ER -